Supplemental Financial Data

6 Months Ended

Jun. 30, 2023

Supplemental Financial Data [Abstract]

Supplemental Financial Data [Text Block]

3. Supplemental Financial Data

Inventories

Our inventory consisted of the following (in thousands):

	June 30, 2023		December 31, 2022
Raw materials:
Raw materials - clinical	$	17,665	$	17,061
Raw materials - commercial		5,585		2,699
Total raw materials		23,250		19,760
Work in process		2,092		2,109
Finished goods		196		164
Total inventory	$	25,538	$	22,033

Accrued Liabilities

Our accrued liabilities consisted of the following (in thousands):

	June 30, 2023		December 31, 2022
Clinical development expenses	$	83,524	$	116,460
In-licensing expenses		7,179		7,945
Commercial expenses		3,151		3,498
Other miscellaneous expenses		10,891		12,198
Total accrued liabilities	$	104,745	$	140,101